EANS-Voting Rights: Marinomed Biotech AG
Publication of a participation
notification according to art. 135 para. 2 Stock Exchange Act
--------------------------------------------------------------------------------
Notification of voting rights transmitted by euro adhoc with the aim of a
Europe-wide distribution. The issuer is responsible for the content of this
announcement.
--------------------------------------------------------------------------------
Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018
Wien, 21.2.2019
Overview
1. Issuer: Marinomed Biotech AG
2. Reason for the notification: Other
3. Person subject to notification obligation
Name: Österreichische Beamtenversicherung, VVaG
City: 1016 Wien
Country: Österreich
4. Name of shareholder(s):
5. Date on which the threshold was crossed or reached: 20.2.2019
6. Total positions
______________________________________________________________________________
| | | % of voting | | |
| | % of voting |rights through |Total of both |Total number of|
| |rights attached|financial/other| in % (7.A + | voting rights |
| |to shares (7.A)| instruments | 7.B) | of issuer |
|_______________|_______________|(7.B.1_+_7.B.2)|______________|_______________|
| Resulting | | | | |
| situation on | | | | |
| the date on | 4,57 % | 0,00 % | 4,57 % | 1 430 772 |
|which threshold| | | | |
| was crossed / | | | | |
|____reached____|_______________|_______________|______________|_______________|
| Position of | | | | |
| previous | | | | |
| notification | | | | |
|(if_applicable)|_______________|_______________|______________|_______________|
Details
7. Notified details of the resulting situation:
______________________________________________________________________________
|A:_Voting_rights_attached_to_shares___________________________________________|
| |____Number_of_voting_rights____|_______%_of_voting_rights_______|
| | Direct | Indirect | Direct | Indirect |
| ISIN Code |(Sec 130 BörseG|(Sec 133 BörseG|(Sec 130 BörseG|(Sec 133 BörseG |
|_____________|_____2018)_____|_____2018)_____|_____2018)_____|_____2018)______|
|ATMARINOMED6_|_________65_321|_______________|_________4,57_%|________________|
|_SUBTOTAL_A__|____________65_321_____________|_____________4,57_%_____________|
______________________________________________________________________________
|B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG |
|2018__________________________________________________________________________|
| | | |Number of voting | |
| | | | rights that may | |
| Type of | | | be | % of voting |
| instrument |Expiration Date|Exercise Period|acquired if the | rights |
| | | | instrument is | |
|_____________|_______________|_______________|____exercised____|______________|
|_____________|_______________|_SUBTOTAL_B.1__|_________________|______________|
_____________________________________________________________________________
|B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG |
|2018_________________________________________________________________________|
| Type of | Expiration | Exercise | Physical / | Number of |% of voting |
|instrument | Date | Period | Cash |voting rights| rights |
|___________|____________|___________|_Settlement__|_____________|____________|
|___________|____________|___________|SUBTOTAL_B.2_|_____________|____________|
8. Information in relation to the person subject to the notification obligation:
Person subject to the notification obligation is not controlled by any natural
person or legal entity and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying) issuer.
9. In case of proxy voting
Date of general meeting: -
Voting rights after general meeting: - is equivalent to - voting rights.
10. Sonstige Kommentare:
Die Österreichische Beamtenversicherung hielt per 19.2.2019 16.383 Aktien der
Marinomed AG.
Durch Wandlung der zuvor gehaltenen Nom. 2 Mio. EUR der 4%V Marinomed-
Wandelanleihe 2017-21
bezog sie per 20.2.2019 48.938 Aktien und hält nunmehr 65.321 Aktien der
Marinomed AG.
Wien am 21.2.2019
end of announcement euro adhoc
--------------------------------------------------------------------------------
issuer: Marinomed Biotech AG
Veterinärplatz 1
A-1210 Wien
phone: 0043250774460
FAX: 0043250774493
mail: office@marinomed.com
WWW: www.marinomed.com
ISIN: ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language: English
Original-Content von: Marinomed Biotech AG, übermittelt durch news aktuell